Breakthrough cancer drug doubles survival in trial
2025-06-01
Hundreds of thousands of people with advanced head and neck cancer could live longer without their cancer returning thanks to an immunotherapy drug, a clinical trial suggests. This is the first sign of a breakthrough for patients with this difficult-to-treat cancer for 20 years, say scientists behind the research. LauraContinue Reading
